Tom Oluoch1, Abraham Katana2, Daniel Kwaro3, Xenophon Santas4, Patrick Langat3, Samuel Mwalili2, Kimeu Muthusi5, Nicky Okeyo3, James K Ojwang2, Ronald Cornet6, Ameen Abu-Hanna7, Nicolette de Keizer7. 1. Division of Global HIV/AIDS, US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya. Electronic address: toluoch@cdc.gov. 2. Division of Global HIV/AIDS, US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya. 3. Kenya Medical Research Institute-CDC Collaborative Program, Kisumu, Kenya. 4. Atlanta, GA, USA. 5. University of California, San Francisco, Nairobi, Kenya. 6. Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Department of Biomedical Engineering, Linköping University, Linköping, Sweden. 7. Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Abstract
BACKGROUND: A clinical decision support system (CDSS) is a computer program that applies a set of rules to data stored in electronic health records to offer actionable recommendations. We aimed to establish whether a CDSS that supports detection of immunological treatment failure among patients with HIV taking antiretroviral therapy (ART) would improve appropriate and timely action. METHODS: We did this prospective, cluster randomised controlled trial in adults and children (aged ≥18 months) who were eligible for, and receiving, ART at HIV clinics in Siaya County, western Kenya. Health facilities were randomly assigned (1:1), via block randomisation (block size of two) with a computer-generated random number sequence, to use electronic health records either alone (control) or with CDSS (intervention). Facilities were matched by type and by number of patients enrolled in HIV care. The primary outcome measure was the difference between groups in the proportion of patients who experienced immunological treatment failure and had a documented clinical action. We used generalised linear mixed models with random effects to analyse clustered data. This trial is registered with ClinicalTrials.gov, number NCT01634802. FINDINGS:Between Sept 1, 2012, and Jan 31, 2014, 13 clinics, comprising 41,062 patients, were randomly assigned to the control group (n=6) or the intervention group (n=7). Data collection at each site took 12 months. Among patients eligible for ART, 10,358 (99%) of 10,478 patients were receiving ART at control sites and 10,991 (99%) of 11,028 patients were receiving ART at intervention sites. Of these patients, 1125 (11%) in the control group and 1342 (12%) in the intervention group had immunological treatment failure, of whom 332 (30%) and 727 (54%), respectively, received appropriate action. The likelihood of clinicians taking appropriate action on treatment failure was higher with CDSS alerts than with no decision support system (adjusted odds ratio 3·18, 95% CI 1·02-9·87). INTERPRETATION:CDSS significantly improved the likelihood of appropriate and timely action on immunological treatment failure. We expect our findings will be generalisable to virological monitoring of patients with HIV receiving ART once countries implement the 2015 WHO recommendation to scale up viral load monitoring. FUNDING: US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centers for Disease Control and Prevention.
RCT Entities:
BACKGROUND: A clinical decision support system (CDSS) is a computer program that applies a set of rules to data stored in electronic health records to offer actionable recommendations. We aimed to establish whether a CDSS that supports detection of immunological treatment failure among patients with HIV taking antiretroviral therapy (ART) would improve appropriate and timely action. METHODS: We did this prospective, cluster randomised controlled trial in adults and children (aged ≥18 months) who were eligible for, and receiving, ART at HIV clinics in Siaya County, western Kenya. Health facilities were randomly assigned (1:1), via block randomisation (block size of two) with a computer-generated random number sequence, to use electronic health records either alone (control) or with CDSS (intervention). Facilities were matched by type and by number of patients enrolled in HIV care. The primary outcome measure was the difference between groups in the proportion of patients who experienced immunological treatment failure and had a documented clinical action. We used generalised linear mixed models with random effects to analyse clustered data. This trial is registered with ClinicalTrials.gov, number NCT01634802. FINDINGS: Between Sept 1, 2012, and Jan 31, 2014, 13 clinics, comprising 41,062 patients, were randomly assigned to the control group (n=6) or the intervention group (n=7). Data collection at each site took 12 months. Among patients eligible for ART, 10,358 (99%) of 10,478 patients were receiving ART at control sites and 10,991 (99%) of 11,028 patients were receiving ART at intervention sites. Of these patients, 1125 (11%) in the control group and 1342 (12%) in the intervention group had immunological treatment failure, of whom 332 (30%) and 727 (54%), respectively, received appropriate action. The likelihood of clinicians taking appropriate action on treatment failure was higher with CDSS alerts than with no decision support system (adjusted odds ratio 3·18, 95% CI 1·02-9·87). INTERPRETATION: CDSS significantly improved the likelihood of appropriate and timely action on immunological treatment failure. We expect our findings will be generalisable to virological monitoring of patients with HIV receiving ART once countries implement the 2015 WHO recommendation to scale up viral load monitoring. FUNDING: US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centers for Disease Control and Prevention.
Authors: Martin C Were; Winstone M Nyandiko; Kristin T L Huang; James E Slaven; Changyu Shen; William M Tierney; Rachel C Vreeman Journal: Pediatrics Date: 2013-02-25 Impact factor: 7.124
Authors: Tom Oluoch; Xenophon Santas; Daniel Kwaro; Martin Were; Paul Biondich; Christopher Bailey; Ameen Abu-Hanna; Nicolette de Keizer Journal: Int J Med Inform Date: 2012-08-24 Impact factor: 4.046
Authors: Frank O Odhiambo; Kayla F Laserson; Maquins Sewe; Mary J Hamel; Daniel R Feikin; Kubaje Adazu; Sheila Ogwang; David Obor; Nyaguara Amek; Nabie Bayoh; Maurice Ombok; Kimberly Lindblade; Meghna Desai; Feiko ter Kuile; Penelope Phillips-Howard; Anna M van Eijk; Daniel Rosen; Allen Hightower; Peter Ofware; Hellen Muttai; Bernard Nahlen; Kevin DeCock; Laurence Slutsker; Robert F Breiman; John M Vulule Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196
Authors: Macarthur Charles; Paul D Leger; Patrice Severe; Colette Guiteau; Alexandra Apollon; Roy M Gulick; Warren D Johnson; Jean W Pape; Daniel W Fitzgerald Journal: J Int AIDS Soc Date: 2012-06-14 Impact factor: 5.396
Authors: Pavel S Roshanov; Shikha Misra; Hertzel C Gerstein; Amit X Garg; Rolf J Sebaldt; Jean A Mackay; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes Journal: Implement Sci Date: 2011-08-03 Impact factor: 7.327
Authors: Adamson S Muula; John Chipeta; Seter Siziya; Emmanuel Rudatsikira; Ronald H Mataya; Edward Kataika Journal: BMC Health Serv Res Date: 2007-12-19 Impact factor: 2.655
Authors: Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons Journal: Am J Epidemiol Date: 2018-09-01 Impact factor: 4.897
Authors: Naomi Muinga; Steve Magare; Jonathan Monda; Onesmus Kamau; Stuart Houston; Hamish Fraser; John Powell; Mike English; Chris Paton Journal: JMIR Med Inform Date: 2018-04-18
Authors: Tom Oluoch; Ronald Cornet; Jacques Muthusi; Abraham Katana; Davies Kimanga; Daniel Kwaro; Nicky Okeyo; Ameen Abu-Hanna; Nicolette de Keizer Journal: BMC Med Inform Decis Mak Date: 2021-12-20 Impact factor: 2.796
Authors: Hamish S F Fraser; Michael Mugisha; Eric Remera; Joseph Lune Ngenzi; Janise Richards; Xenophon Santas; Wayne Naidoo; Christopher Seebregts; Jeanine Condo; Aline Umubyeyi Journal: JMIR Med Inform Date: 2022-05-03